Clinical study of drotaverine combined with lornoxicam in the treatment of acute renal colic

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039501

Enrollment

Unknown

Registered

2020-10-30

Start date

2020-11-07

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute renal colic

Interventions

Experimental group:Give intravenous lornoxicam 8mg + intravenous drip drotaverine 80mg

Control group:Lornoxicam 8mg intravenously + Phloroglucinol 120mg intravenously

Blank control group:Give intravenous lornoxicam 8mg

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with acute renal colic caused by ureteral calculi obstruction was confirmed by imaging examination.

Exclusion criteria

Exclusion criteria: 1. Minors; 2. Pregnant women and breast-feeding patients; 3. Patients with severe cardiovascular disease; 4. Patients allergic to drugs.

Design outcomes

Primary

Measure	Time frame
Pain score;	—

Secondary

Measure	Time frame
Analgesic dosage;medical side effects;	—

Countries

China

Contacts

Public ContactYongliang Ni

Shandong Provincial Third Hospital

nyl_cabin@163.com+86 18613699256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026